Jack Kachkar

From Wikipedia, the free encyclopedia

Jack Kachkar (b. February 19, 1963) is CEO of Inyx, Inc, a speciality pharmaceutical company founded in 2003. In addition to focusing on investments in the healthcare industry, Jack Kachkar also currently manages his family's real estate and commodities investments.

Kachkar was born in Damascus, Syria. His father was of Syrian-Armenian ancestry (Mihran Missak Kachkar; nee Kachkarian).

Jack immigrated to Canada in September, 1969 from Lebanon. He attended School and University of Alberta in Edmonton prior to transferring to Hungary where he attained a medical degree, summa cum lauda. He tried to purchase Olympique de Marseille football club in early 2007. [1] Marseilles' boss broke off talks in March 2007 with Kachkar after the Canadian businessman asked for a delay for further due diligence required by his bankers to pay the 115mil euro price that had been set for him to take over the former European champions.

In 2005, the High Court in Ireland ruled in favour of restricting Dr Jack Kachkar under the Companies Act: Mitek Holdings Ltd v Companies Act [2005] IEHC 63.^[1] The order has been stayed pending an appeal to the Irish Supreme Court.^[2]

On June 28th 2007 Ashton Pharmaceuticals and Inyx Pharma were put into administration by Westernbank of Puerto Rico, Inyx, Inc's primary lender (Ernst & Young). Jack Kachkar and Inyx, Inc. filed lender's liability lawsuits against Westernbank for taking unilateral damaging actions against the company, despite waivers provided to Inyx by the bank, and a forbearance agreement between the parties. Father of Michael Kachkar unfortunately. Rumours of a murder attempt on Jack Kachkar cannot be confirmed. If it did happen there would be about 10,000 suspects

[edit] References